N
About
GlycemiaCareNavonTech has developed GlycemiaCare - a noninvasive wearable technology for the identification of Nocturnal Hypoglycemia. Hypoglycemia is a drop of the blood glucose level, and it is a complication associated with treatment by Insulin and is experienced by many diabetics. When it happens at night, the diabetic may not feel it and risk significant morbidity and mortality. 5% of Insulin-dependent diabetics die because of undetected nocturnal hypoglycemia.
Tags
Total Employees
3
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
20Traction
6Team
0Visibility
3Profile
40Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does NavonTech do?
GlycemiaCareNavonTech has developed GlycemiaCare - a noninvasive wearable technology for the identification of Nocturnal Hypoglycemia. Hypoglycemia is a drop of the blood glucose level, and it is a complication associated with treatment by Insulin and is experienced by many diabetics. When it happens at night, the diabetic may not feel it and risk significant morbidity and mortality. 5% of Insulin-dependent diabetics die because of undetected nocturnal hypoglycemia.
When was NavonTech founded?
NavonTech was founded in 2017.
What industry does NavonTech operate in?
NavonTech operates in Healthcare, Monitor, Diabetes.
How many employees does NavonTech have?
NavonTech has approximately 3 people on record.
What is NavonTech's current status?
NavonTech's current operating status is: Inactive.